Advertisement
Screener

SYNLOGIC, INC. (SYBX) Increase (Decrease) in Accounts Payable and Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

SYNLOGIC, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities

SYNLOGIC, INC. (SYBX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $98.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-11

  • SYNLOGIC, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$247.00K.
  • SYNLOGIC, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $345.00K.
  • SYNLOGIC, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $53.00K, a 80.15% decline year-over-year.
  • SYNLOGIC, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$32.00K.
  • SYNLOGIC, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$1.18M.
  • SYNLOGIC, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$2.26M.
  • SYNLOGIC, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$2.65M, a 480.63% decline from fiscal 2022.
  • SYNLOGIC, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $697.00K, a 29.55% increase from fiscal 2021.
Period endIncrease (Decrease) in Accounts Payable and Accrued Liabilities 3 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 6 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 9 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 12 month
2026-06-30-$247.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
$98.00K
10-Q · filed 2026-08-11
$151.00K
derived: sum of 3 quarters · filed 2026-08-11
$119.00K
derived: sum of 4 quarters · filed 2026-08-11
2026-03-31$345.00K
10-Q · filed 2026-05-14
$398.00K
derived: sum of 2 quarters · filed 2026-05-14
$366.00K
derived: sum of 3 quarters · filed 2026-05-14
$337.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-12-31$53.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$21.00K
derived: sum of 2 quarters · filed 2026-03-12
-$8.00K
derived: sum of 3 quarters · filed 2026-08-11
-$1.18M
10-K · filed 2026-03-12
2025-09-30-$32.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$61.00K
derived: sum of 2 quarters · filed 2026-08-11
-$1.24M
10-Q · filed 2025-11-13
-$969.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-06-30-$29.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
-$1.20M
10-Q · filed 2026-08-11
-$937.00K
derived: sum of 3 quarters · filed 2026-08-11
-$1.43M
derived: sum of 4 quarters · filed 2026-08-11
2025-03-31-$1.18M
10-Q · filed 2026-05-14
-$908.00K
derived: sum of 2 quarters · filed 2026-05-14
-$1.40M
derived: sum of 3 quarters · filed 2026-05-14
-$2.81M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$267.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$222.00K
derived: sum of 2 quarters · filed 2026-03-12
-$1.63M
derived: sum of 3 quarters · filed 2026-03-12
-$2.26M
10-K · filed 2026-03-12
2024-09-30-$489.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$1.90M
derived: sum of 2 quarters · filed 2025-11-13
-$2.52M
10-Q · filed 2025-11-13
-$2.49M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$1.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$2.03M
10-Q · filed 2025-08-07
-$2.00M
derived: sum of 3 quarters · filed 2025-08-07
-$2.24M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31-$622.00K
10-Q · filed 2025-05-08
-$587.00K
derived: sum of 2 quarters · filed 2025-05-08
-$825.00K
derived: sum of 3 quarters · filed 2025-05-08
-$897.00K
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$35.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06
-$203.00K
derived: sum of 2 quarters · filed 2025-03-06
-$275.00K
derived: sum of 3 quarters · filed 2025-03-06
-$2.65M
10-K · filed 2025-03-06
2023-09-30-$238.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$310.00K
derived: sum of 2 quarters · filed 2024-11-12
-$2.69M
10-Q · filed 2024-11-12
-$2.10M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$72.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$2.45M
10-Q · filed 2024-08-08
-$1.86M
derived: sum of 3 quarters · filed 2024-08-08
-$154.00K
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$2.38M
10-Q · filed 2024-05-14
-$1.79M
derived: sum of 2 quarters · filed 2024-05-14
-$82.00K
derived: sum of 3 quarters · filed 2024-05-14
-$294.00K
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$590.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
$2.30M
derived: sum of 2 quarters · filed 2024-03-19
$2.08M
derived: sum of 3 quarters · filed 2024-03-19
$697.00K
10-K · filed 2024-03-19
2022-09-30$1.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$1.49M
derived: sum of 2 quarters · filed 2023-11-09
$107.00K
10-Q · filed 2023-11-09
$190.00K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30-$212.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
-$1.60M
10-Q · filed 2023-08-10
-$1.52M
derived: sum of 3 quarters · filed 2023-08-10
-$801.00K
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$1.39M
10-Q · filed 2023-05-11
-$1.30M
derived: sum of 2 quarters · filed 2023-05-11
-$589.00K
derived: sum of 3 quarters · filed 2023-05-11
$559.00K
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$83.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29
$798.00K
derived: sum of 2 quarters · filed 2023-03-29
$1.95M
derived: sum of 3 quarters · filed 2023-03-29
$538.00K
10-K · filed 2023-03-29
2021-09-30$715.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$1.86M
derived: sum of 2 quarters · filed 2022-11-10
$455.00K
10-Q · filed 2022-11-10
$1.95M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$1.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
-$260.00K
10-Q · filed 2022-08-11
$1.23M
derived: sum of 3 quarters · filed 2022-08-11
$1.92M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$1.41M
10-Q · filed 2022-05-12
$86.00K
derived: sum of 2 quarters · filed 2022-05-12
$767.00K
derived: sum of 3 quarters · filed 2022-05-12
$372.00K
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$1.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17
$2.17M
derived: sum of 2 quarters · filed 2022-03-17
$1.78M
derived: sum of 3 quarters · filed 2022-03-17
-$349.00K
10-K · filed 2022-03-17
2020-09-30$681.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$286.00K
derived: sum of 2 quarters · filed 2021-11-10
-$1.84M
10-Q · filed 2021-11-10
-$2.11M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$395.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$2.52M
10-Q · filed 2021-08-12
-$2.79M
derived: sum of 3 quarters · filed 2021-08-12
-$3.19M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$2.13M
10-Q · filed 2021-05-13
-$2.39M
derived: sum of 2 quarters · filed 2021-05-13
-$2.79M
derived: sum of 3 quarters · filed 2021-05-13
-$1.98M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31-$265.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
-$662.00K
derived: sum of 2 quarters · filed 2021-03-25
$149.00K
derived: sum of 3 quarters · filed 2021-03-25
-$935.00K
10-K · filed 2021-03-25
2019-09-30-$397.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$414.00K
derived: sum of 2 quarters · filed 2020-11-05
-$670.00K
10-Q · filed 2020-11-05
-$335.00K
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$811.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$273.00K
10-Q · filed 2020-08-06
$62.00K
derived: sum of 3 quarters · filed 2020-08-06
$736.00K
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31-$1.08M
10-Q · filed 2020-05-08
-$749.00K
derived: sum of 2 quarters · filed 2020-05-08
-$75.00K
derived: sum of 3 quarters · filed 2020-05-08
$1.63M
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31$335.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
$1.01M
derived: sum of 2 quarters · filed 2020-03-12
$2.72M
derived: sum of 3 quarters · filed 2020-03-12
-$257.00K
10-K · filed 2020-03-12
2018-09-30$674.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$2.38M
derived: sum of 2 quarters · filed 2019-11-12
-$592.00K
10-Q · filed 2019-11-12
$533.00K
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$1.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$1.27M
10-Q · filed 2019-08-08
-$141.00K
derived: sum of 3 quarters · filed 2019-08-08
$1.55M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31-$2.98M
10-Q · filed 2019-05-09
-$1.85M
derived: sum of 2 quarters · filed 2019-05-09
-$159.00K
derived: sum of 3 quarters · filed 2019-05-09
$1.14M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31$1.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
$2.82M
derived: sum of 2 quarters · filed 2019-03-12
$4.11M
derived: sum of 3 quarters · filed 2019-03-12
$4.07M
10-K · filed 2019-03-12
2017-09-30$1.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
$2.99M
derived: sum of 2 quarters · filed 2018-11-13
$2.95M
10-Q · filed 2018-11-13
$3.70M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30$1.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$1.25M
10-Q · filed 2018-08-09
$2.01M
derived: sum of 3 quarters · filed 2018-08-09
2017-03-31-$41.00K
10-Q · filed 2018-05-15
$717.00K
derived: sum of 2 quarters · filed 2018-05-15
2016-12-31$758.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20
$1.33M
10-K · filed 2018-03-20
2016-09-30$571.00K
10-Q · filed 2017-11-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bolt Biotherapeutics, Inc. (BOLT)United States$0.007B-0.26
Enveric Biosciences, Inc. (ENVB)United States$0.007B-0.63
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Ernexa Therapeutics Inc. (ERNA)United States$0.006B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
Pulmatrix, Inc. (PULM)United States$0.006B
EXICURE, INC. (XCUR)United States$0.008B-1.54